Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma.

IF 2.1 Q3 ONCOLOGY
International Journal of Particle Therapy Pub Date : 2021-10-18 eCollection Date: 2022-01-01 DOI:10.14338/IJPT-21-00010
Ashley Way, Savas Ozdemir, Barbara Berges, Nataliya Getman, Xiaoying Liang, Nancy P Mendenhall, Graham Collins, David Cutter, Raymond B Mailhot Vega
{"title":"Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma.","authors":"Ashley Way, Savas Ozdemir, Barbara Berges, Nataliya Getman, Xiaoying Liang, Nancy P Mendenhall, Graham Collins, David Cutter, Raymond B Mailhot Vega","doi":"10.14338/IJPT-21-00010","DOIUrl":null,"url":null,"abstract":"<p><p>We present a case of recurrent pericardial effusion presenting during proton therapy in a 24-year-old female receiving mediastinal treatment for classical Hodgkin lymphoma. Pericardial effusion is typically considered an event accompanying lymphoma diagnosis or as a subacute or late effect of radiotherapy. Rarely has it been described as occurring during radiation treatment with photon-based radiotherapy, let alone proton therapy. It is unclear what underlying cause triggered recurrent effusion in this patient. Identifying and managing pericardial effusion during treatment delivery is important to consider as it may affect radiation dosimetry, particularly with proton therapy. Doing so will help ensure patients receive optimal treatment and minimize the risks of morbidity and mortality.</p>","PeriodicalId":36923,"journal":{"name":"International Journal of Particle Therapy","volume":"8 1","pages":"76-81"},"PeriodicalIF":2.1000,"publicationDate":"2021-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009456/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Particle Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14338/IJPT-21-00010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We present a case of recurrent pericardial effusion presenting during proton therapy in a 24-year-old female receiving mediastinal treatment for classical Hodgkin lymphoma. Pericardial effusion is typically considered an event accompanying lymphoma diagnosis or as a subacute or late effect of radiotherapy. Rarely has it been described as occurring during radiation treatment with photon-based radiotherapy, let alone proton therapy. It is unclear what underlying cause triggered recurrent effusion in this patient. Identifying and managing pericardial effusion during treatment delivery is important to consider as it may affect radiation dosimetry, particularly with proton therapy. Doing so will help ensure patients receive optimal treatment and minimize the risks of morbidity and mortality.

化疗难治性霍奇金淋巴瘤患者质子治疗期间心包积液
我们报告一例24岁女性在质子治疗期间复发性心包积液,该女性接受纵隔治疗,治疗经典霍奇金淋巴瘤。心包积液通常被认为是伴随淋巴瘤诊断的事件,或是放疗的亚急性或晚期影响。很少有人描述它发生在光子放射治疗的放射治疗过程中,更不用说质子治疗了。目前尚不清楚是什么根本原因导致该患者反复出现积液。在治疗过程中识别和管理心包积液很重要,因为它可能会影响辐射剂量测定,尤其是质子治疗。这样做将有助于确保患者得到最佳治疗,并将发病率和死亡率风险降至最低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Particle Therapy
International Journal of Particle Therapy Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
3.70
自引率
5.90%
发文量
23
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信